You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 17, 2024

CLINICAL TRIALS PROFILE FOR NAROPIN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for naropin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00562627 ↗ Efficacy of Multimodal Peri- and Intraarticular Drug Injections in Total Knee Arthroplasty Completed Asker & Baerum Hospital Phase 4 2007-11-01 Total knee arthroplasty (TKA) is associated with moderate to severe postoperative pain, causing patient discomfort, mobilisation and hospital discharge. The aim of this study is to: 1. Compare analgetic efficacy of to types of local infiltration analgesia in total knee arthroplasty. 2. Compare analgetic efficacy of local infiltration analgesia with continuous epidural analgesia.
NCT00573963 ↗ Efficacy of the Transversus Abdominus Plane (TAP) Block for Post-Cesarean Delivery Analgesia Completed Samuel Lunenfeld Research Institute, Mount Sinai Hospital N/A 2007-12-01 The purpose of this study is to determine if patients having the transversus abdominal place (TAP) block at the end of a cesarean delivery have less pain in the post-delivery period than those who do not. Freezing medication is injected between the layers of muscle on either side of the belly, to freeze the nerves that carry pain stimuli from an abdominal wound. This technique has been useful for many abdominal operations, and has recently been studied in cesarean sections, however more information is needed.
NCT00603083 ↗ Postoperative Pain Treatment in Total Hip Arthroplasty: A Study to Assess the Effect of Local Analgesia Completed Vejle Hospital Phase 4 2008-01-01 The purpose of this study is to determine whether the investigator standardized pain treatment plus local pain treatment is more effective than the investigator standardized pain treatment plus placebo in total hip arthroplasty.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for naropin

Condition Name

Condition Name for naropin
Intervention Trials
Pain, Postoperative 24
Pain 16
Postoperative Pain 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for naropin
Intervention Trials
Pain, Postoperative 47
Osteoarthritis 12
Fractures, Bone 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for naropin

Trials by Country

Trials by Country for naropin
Location Trials
United States 77
Denmark 14
Canada 14
China 9
Singapore 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for naropin
Location Trials
Ohio 7
Florida 6
Texas 5
Michigan 5
North Carolina 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for naropin

Clinical Trial Phase

Clinical Trial Phase for naropin
Clinical Trial Phase Trials
Phase 4 71
Phase 3 20
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for naropin
Clinical Trial Phase Trials
Completed 93
Recruiting 19
Withdrawn 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for naropin

Sponsor Name

Sponsor Name for naropin
Sponsor Trials
Boston Children's Hospital 6
Duke University 5
Boston Children’s Hospital 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for naropin
Sponsor Trials
Other 215
Industry 12
U.S. Fed 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.